Maplebear (NASDAQ:CART) and OptimizeRx (NASDAQ:OPRX) Financial Contrast

Maplebear (NASDAQ:CART) and OptimizeRx (NASDAQ:OPRX) are both retail/wholesale companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Profitability

This table compares Maplebear and OptimizeRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Maplebear	13.37%	13.78%	10.51%
OptimizeRx	-27.41%	-4.92%	-3.41%

Risk & Volatility

Maplebear has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Maplebear and OptimizeRx, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Maplebear	0	13	13	0	2.50
OptimizeRx	0	2	6	0	2.75

Maplebear currently has a consensus target price of $47.14, suggesting a potential upside of 12.18%. OptimizeRx has a consensus target price of $9.71, suggesting a potential upside of 97.85%. Given OptimizeRx’s stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than Maplebear.

Earnings and Valuation

This table compares Maplebear and OptimizeRx”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Maplebear	$3.30 billion	3.27	-$1.62 billion	$1.49	28.20
OptimizeRx	$88.18 million	1.03	-$17.57 million	($1.33)	-3.69

OptimizeRx has lower revenue, but higher earnings than Maplebear. OptimizeRx is trading at a lower price-to-earnings ratio than Maplebear, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

63.1% of Maplebear shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 36.0% of Maplebear shares are held by company insiders. Comparatively, 6.1% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Maplebear beats OptimizeRx on 9 of the 14 factors compared between the two stocks.

About Maplebear

Maplebear Inc., doing business as Instacart, engages in the provision of online grocery shopping services to households in North America. It sells and delivers grocery products, as well as pickup services through a mobile application and website. It also operates virtual convenience stores; and provides software-as-a-service solutions to retailers. The company was incorporated in 2012 and is based in San Francisco, California.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.